ARTICLE | Finance
Vaccine volatility
Assessing fallout from vaccine scandal, trade war on Chinese biopharma stocks
August 17, 2018 10:33 PM UTC
The last two weeks have not been kind to biopharma companies listed on Chinese exchanges, and Thursday’s announcements regarding the resignations of officials over a vaccine scandal could further dampen sentiment.
Earlier this month, the Shenzhen Stock Exchange publicly reprimanded six senior executives at Changsheng Bio-Technology Co. Ltd. (SZSE:002680) after the company allegedly violated manufacturing quality controls by falsifying production records for freeze-dried human rabies vaccines (see “Safety, Trade Concerns Weigh on China Biotechs”)...